No connection

Search Results

AMS vs TNON

AMS
American Shared Hospital Services
BEARISH
Price
$1.33
Market Cap
$8.8M
Sector
Healthcare
AI Confidence
95%
TNON
Tenon Medical, Inc.
BEARISH
Price
$0.80
Market Cap
$9.0M
Sector
Healthcare
AI Confidence
90%

Valuation

P/E Ratio
AMS
--
TNON
--
Forward P/E
AMS
3.34
TNON
-1.28
P/B Ratio
AMS
0.37
TNON
4.41
P/S Ratio
AMS
0.31
TNON
2.29
EV/EBITDA
AMS
8.29
TNON
-0.72

Profitability

Gross Margin
AMS
38.31%
TNON
59.79%
Operating Margin
AMS
-13.98%
TNON
-193.52%
Profit Margin
AMS
-5.53%
TNON
0.0%
ROE
AMS
-9.45%
TNON
-228.06%
ROA
AMS
-2.18%
TNON
-72.88%

Growth

Revenue Growth
AMS
-14.8%
TNON
92.3%
Earnings Growth
AMS
--
TNON
--

Financial Health

Debt/Equity
AMS
0.78
TNON
0.03
Current Ratio
AMS
0.76
TNON
2.11
Quick Ratio
AMS
0.71
TNON
1.7

Dividends

Dividend Yield
AMS
--
TNON
--
Payout Ratio
AMS
0.0%
TNON
0.0%

AI Verdict

AMS BEARISH

AMS exhibits severe financial distress, anchored by a weak Piotroski F-Score of 2/9 and a critical liquidity position with a current ratio of 0.76. The company is experiencing a systemic decline, evidenced by a -14.80% YoY revenue contraction and a disastrous -200% YoY EPS growth. Despite a low Price-to-Book ratio of 0.37, the stock is in a technical freefall (0/100 trend) and consistently misses earnings estimates by wide margins. The combination of negative profitability and shrinking top-line growth suggests a value trap rather than a value opportunity.

Strengths
Positive Gross Margin (38.31%)
Low Price-to-Book ratio (0.37)
Low Price-to-Sales ratio (0.31)
Risks
Severe liquidity risk (Current Ratio 0.76 < 1.0)
Negative revenue growth (-14.80% YoY)
Consistent and massive earnings misses (Recent surprise -550%)
TNON BEARISH

TNON exhibits critical financial fragility with a Piotroski F-Score of 1/9, signaling severe weakness in profitability and operational efficiency. While the company shows impressive top-line momentum with 92.3% YoY revenue growth and maintains a low debt profile, these are overshadowed by a catastrophic -193.52% operating margin and a -228.06% ROE. The long-term price performance is devastating, with a near 100% loss over 5 years, suggesting a failed historical value proposition. Despite optimistic analyst price targets, the deterministic health metrics indicate a high risk of continued equity erosion.

Strengths
Strong YoY revenue growth of 92.30%
High gross margin of 59.79% indicating product value
Very low leverage with a Debt/Equity ratio of 0.03
Risks
Critical financial health as evidenced by Piotroski F-Score of 1/9
Severe operational losses with an operating margin of -193.52%
Extreme equity erosion indicated by ROE of -228.06%

Compare Another Pair

AMS vs TNON: Head-to-Head Comparison

This page compares American Shared Hospital Services (AMS) and Tenon Medical, Inc. (TNON) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile